Quick answer
The Long-term Enhanced ACO Design (LEAD) model is CMS's ten-year successor to ACO REACH. It starts January 1, 2027 and runs through 2036, with two risk options (Global and Professional), benchmarks that are not rebased during the model, and a new voluntary component called CARA (CMS-Administered Risk Arrangements) that lets ACOs in the Global option enter episode-based, two-sided risk arrangements with specialists while CMS handles the episode accounting. For referrals, the implication is direct: savings won by steering patients to high-value in-network specialists are no longer ratcheted away in the next benchmark, and specialists now have formal ways to share accountability. Referral steerage becomes a long-term asset that compounds.
Key takeaways
- LEAD replaces ACO REACH when REACH ends on December 31, 2026.
- No mid-model rebasing means early referral gains are not penalized in later years.
- CARA makes ACO-specialist risk arrangements administratively feasible for the first time.
- Specialists can participate as Participant Providers or Preferred Providers.
- The ACOs that win will know, by specialty and by specialist, where their referrals go and what those episodes cost.
What LEAD changes, at a glance
| Feature | ACO REACH | LEAD (from 2027) |
|---|---|---|
| Duration | Ends December 31, 2026 | 10 years, 2027–2036 |
| Benchmark approach | Periodic updates that could ratchet down after savings | Fixed historical baseline with annual trend updates, no mid-model rebasing |
| Risk options | Professional and Global | Professional (up to 50%) and Global (up to 100%) |
| Specialist engagement | Preferred provider arrangements allowed but rarely used | Participant and Preferred Provider paths, plus CARA episode arrangements |
| Episode data for specialist contracts | Shadow bundles data | CARA builds on shadow bundles with CMS-administered reconciliation |
| Small and rural support | Limited | Infrastructure support and ramp-up for new entrants |
Why the benchmark change matters for referrals
Under models that rebase, an ACO that cut specialty spend in years one and two could see a lower benchmark in year three, shrinking the reward for the same performance. LEAD's fixed baseline removes much of that ratchet. Every point of out-of-network leakage the ACO eliminates in 2027 keeps paying for the life of the model.
That turns several referral metrics into strategic ones:
- In-network rate (keepage) by specialty and by participant practice.
- Cost per episode for the specialists receiving the most referrals.
- Time to appointment, because delays push patients to emergency departments and outside specialists.
- Closed-loop rate, because quality scoring depends on specialist information returning to primary care.
What CARA means for your specialist network
CARA is a voluntary part of LEAD available to ACOs in the Global Risk option. It builds on the shadow bundles data CMS has provided since 2024 and lets ACOs and specialists enter defined, episode-based risk arrangements using standardized structures, with CMS performing the episode accounting and reconciliation. Historically, the barrier to specialist risk-sharing was not willingness; it was the infrastructure to define episodes, share data, and settle payments. CARA addresses that administrative layer.
But CARA does not decide which specialists should be in those arrangements or whether referrals actually reach them. That still depends on the ACO's own referral data and workflows:
| CARA question | Referral data you need |
|---|---|
| Which specialists should we contract with? | Cost, quality, and access by specialist from claims |
| Which episodes matter most? | Referral volume and spend by condition and specialty |
| Will patients actually go to contracted specialists? | Point-of-order steerage inside the EHR |
| Are the arrangements working? | Keepage, episode cost, and closed-loop rate over time |
ReferralPoint's IntelligentDATA scores specialists from claims across cost, quality, and access dimensions, NetworkMANAGEMENT maps steerage across the network, and Auto IdealMATCH puts the recommended in-network specialist in front of the clinician at the moment of order.
Specialist participation paths
LEAD gives specialists more than an informal referral relationship:
- Participant Provider — the specialist practice joins the ACO, with whole-practice accountability and potential shared savings or losses.
- Preferred Provider — a narrower, contract-based collaboration.
- CARA arrangements — defined episode-based risk with an ACO, administered by CMS.
For specialty practices, this is a reason to invest in measurable referral responsiveness now. ACOs choosing partners will favor practices that accept referrals quickly, schedule fast, and send consult notes back reliably. Our specialist solutions page covers the inbound side.
A referral readiness plan for LEAD performance year one
- Baseline leakage now. Measure out-of-network rate and spend by specialty for your aligned population using 2025–2026 claims. Our leakage guide shows the math.
- Tier your specialists. Rank specialists by risk-adjusted episode cost, quality, access, and loop closure. Identify CARA candidates in your top five spend specialties.
- Embed steerage at the point of order. Preferred lists in a PDF do not change behavior; recommendations inside the EHR referral workflow do.
- Remove access delays. Automate prior authorization and patient scheduling so patients do not leak while waiting.
- Close every loop. Require consult note return from preferred and CARA specialists, and track it.
- Report monthly. Put keepage, episode cost, time to appointment, and closed-loop rate in front of the ACO board.
Many ACOs will run MSSP and LEAD side by side. Our MSSP referral playbook covers the shared strategies.
What results look like
ReferralPoint customers have documented the kind of referral improvements that compound under a fixed benchmark: VillageMD Houston raised keepage from 35% to 65% and documented $8M in Year 1 referral cost savings followed by $9M in Year 2; Vanguard Medical Group cut out-of-network referrals from 33% to 8%; Privia Medical Group North Texas reduced referral cost 45%. Sources are on our facts page.
Bottom line
LEAD rewards ACOs for controlling where referrals go, and keeps rewarding them for a decade. CARA gives you the contract structure with specialists; you still need the data to choose them and the workflow to get patients there. Request a demo to see your specialist network scored and steered before performance year one.
FAQ
Q: What is the LEAD model? A: The Long-term Enhanced ACO Design model is a voluntary, ten-year CMS Innovation Center ACO model that replaces ACO REACH starting January 1, 2027, with Global and Professional risk options and benchmarks that are not rebased during the model.
Q: When does the LEAD model start? A: January 1, 2027. ACO REACH ends December 31, 2026.
Q: What is CARA in the LEAD model? A: CMS-Administered Risk Arrangements, a voluntary component for ACOs in the Global Risk option that supports episode-based, two-sided risk arrangements with specialists, with CMS handling episode accounting and reconciliation.
Q: How does the LEAD model affect referral management? A: Without rebasing, savings from steering referrals to high-value in-network specialists persist across the model, and CARA creates formal ways to share risk with those specialists. Referral data and point-of-order steerage become central to performance.
Q: Can specialists participate in the LEAD model? A: Yes, as Participant Providers, Preferred Providers, or through CARA arrangements with ACOs.
Q: What referral metrics should a LEAD ACO track? A: In-network rate by specialty and practice, risk-adjusted episode cost by specialist, time to appointment, prior authorization turnaround, and closed-loop rate.
Sources and notes
LEAD and CARA details are from CMS Innovation Center announcements (December 2025 and the March 31, 2026 Request for Applications) and published legal and policy analyses. Model terms may change; confirm with CMS. ReferralPoint outcomes are on our sourced metrics page. This post is general information, not legal or financial advice.



